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Abstract
The innate immune response to West Nile virus (WNV) infection involves recognition through toll-like receptors (TLRs) and
RIG-I-like receptors (RLRs), leading to establishment of an antiviral state. MiRNAs (miRNAs) have been shown to be reliable
biomarkers of TLR activation. Here, we sought to evaluate the contribution of TLR3 and miRNAs to the host response to
WNV infection. We first analyzed HEK293-NULL and HEK293-TLR3 cells for changes in the innate immune response to
infection. The presence of TLR3 did not seem to affect WNV load, infectivity or phosphorylation of IRF3. Analysis of
experimentally validated NFkB-responsive genes revealed a WNV-induced signature largely independent of TLR3. Since
miRNAs are involved in viral pathogenesis and the innate response to infection, we sought to identify changes in miRNA
expression upon infection in the presence or absence of TLR3. MiRNA profiling revealed 70 miRNAs induced following WNV
infection in a TLR3-independent manner. Further analysis of predicted gene targets of WNV signature miRNAs revealed
genes highly associated with pathways regulating cell death, viral pathogenesis and immune cell trafficking.
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Introduction
West Nile Virus (WNV) is a mosquito-borne neurotropic
flavivirus, and closely related to Yellow Fever Virus (YFV) and
Dengue virus (DENV). WNV is an enveloped virus and contains a
single-stranded, positive-sense RNA genome. The genomic RNA
is translated into a single polyprotein, and during viral RNA
synthesis dsRNA intermediates are generated in the cytoplasm.
WNV is transmitted by mosquitoes and is an emerging pathogen,
especially in the Americas, with 5,674 and 2,469 reported cases of
WNV in the United States in 2012 and 2013, respectively. [1,2,3].
In 2013, 1,494 people were hospitalized with WNV infection with
nearly a 10% fatality rate (119/1494) [3]. Cases of WNV
transmission by blood transfusion have also been reported [4].
Generally, WNV infection is asymptomatic, although in a small
percentage of patients WNV infection can lead to fatal enceph-
alitis, specifically in the elderly, transplant recipients and other
immune-compromised hosts including patients infected with HIV.
This suggests a pivotal role for the immune response in
determining systemic WNV pathogenesis [5].
The innate immune system uses pattern recognition receptors
(PRRs) that recognize specific, conserved pathogen-associated
molecular patterns (PAMPs)[6]. Several of these PRRs trigger the
secretion of type I interferon as part of the innate immune
response. The PRRs that have been implicated in triggering the
innate response to WNV infection are toll-like receptor (TLR) 3
and 7, Retinoic acid Inducible Gene -I (RIG-I), Melanoma
Differentiation Associated protein 5 (MDA5), RIG-I-like receptor
3 (LGP2), and Protein Kinase R (PKR) [7,8,9,10]. These PRRs
recognize single-stranded and/or double-stranded RNA, such as
the intermediates created by the replicating WNV genome. PRR
engagement triggers a signaling cascade leading to the activation
of signature transcriptional regulators. Profiling transcriptional
events thus provides a means to understand virus infection and
innate signaling events. Notably among these transcription factors
are NF-kB and IRF-3, which induce inflammatory cytokines, such
as type I interferon (IFN-a/b) [11,12,13]. The lack of the
cytoplasmic helicases MDA5 and RIG-I is associated with a
failure to generate an effective immune response to WNV in
experimentally infected mice [6,12,14,15,16,17]. The common
adapter protein for RIG-I and MDA5, MAVS, has been shown to
be essential for triggering innate immunity and control of WNV
pathogenesis [16,17]. The absence of PKR signaling or a deficient
29-59 oligoadenylate synthase (OAS)/RNaseL pathway also lead to
increased susceptibility to WNV infection [18,19,20,21,22,23].
TLR7 affects homing of immune cells to the infection site in vivo
[24]. In sum, multiple and perhaps redundant PRR signaling
pathways respond to WNV infection.
TLR3 has a complicated role in the innate response to WNV.
In experimentally infected mice, TLR3 can enhance WNV
pathogenesis but also protect the host from viral dissemination,
CNS inflammation and virulence [25,26,27]. TLR3-deficient mice
show increased lethal WNV infection and elevated viral burden in
the brain compared to wild type mice [25]. TLR3 seems to restrict
replication in neurons, leading to decreased neuronal cell death in
mice [25]. TLR3 has also been reported to initiate an
inflammatory response that leads to breakdown of the blood
brain barrier and penetration of WNV, resulting in increased viral
load within the brain and increased lethal WNV infection [27].
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Less is known about TLR3’s cell autonomous role in WNV
infection. Studies of WNV in culture have focused on the role of
individual WNV proteins, such as the nonstructural protein NS1.
Expression of NS1 was shown to inhibit TLR3-induced interferon
and NFkB activation and to abrogate the TLR3-mediated
antiviral response in HeLa and HEK293 cells [28,29]. Others
reported that transient or stable expression of NS1 proteins from
WNV and two related flaviviruses failed to inhibit TLR3 signaling
in HeLa and HEK293 cells [30].
To further our understanding of the role of TLR3 in WNV
infection, we turned to microRNA (miRNA) profiling as a novel
tool to characterize the host response. MiRNAs are a class of 21 to
25-nt non-coding RNAs that are conserved across species,
including humans and insects. They modulate a wide range of
cellular processes such as cell cycle control, replication, apoptosis
and immunity [31,32]. MiRNA expression can also be altered
upon stimulation of TLR signaling. Activation of TLR3 by
polyI:C treatment induces miR-29b, miR-29c, miR-148b and
miR-152 in tumor cell lines [33]. TLR3 has also been shown to
upregulate expression of miR-155, miR-146 and miR-147 in
monocytes and macrophages [34,35]. Some viruses employ
virally-encoded miRNAs to mediate establishment of a persistent
or latent viral infection. Although flaviviruses themselves are not
known to encode miRNAs in mammalian cells [36,37], KUN-
miR-1, a small RNA derived from the WNV 39 UTR, has been
discovered in infected mosquito cells and affects viral replication
[38]. Slonchak et al. also found that in Aedes albopictus cells,
WNV infection downregulates mosquito-specific aae-miR-2940 to
restrict viral replication [39]. In mammalian cells, it is likely that
the host cell utilizes miRNAs that can affect its ability to fight off
viral infection, either indirectly by targeting key innate immune
signaling molecules or by directly binding to the viral genome.
Conversely, the WNV may generally suppress or specifically
modulate the cellular miRNA profile to benefit viral replication
and spread [40,41,42,43]. Virus-derived small RNAs may also
play a functional role in the response to WNV infection [44].
Smith et al. found that cellular miRNA hs_154 was induced by
WNV infection and contributed to virus-mediated cell death in
HEK293 and SK-N-MC cells [37]. Therefore, a comprehensive
analysis of miRNA expression following WNV infection may
reveal additional miRNAs important for viral pathogenesis and
provide insight into the regulation of the miRNA response to
WNV.
In this study, we determined the effect of WNV infection on the
cellular miRNA repertoire using quantitative real-time PCR assays
(TaqMan) directed against ,450 well validated human miRNAs.
Since TLR3 signaling plays an important but complicated role in
WNV infection, we analyzed the miRNA profile in the presence
and absence of TLR3. The cellular response to infection (pIRF3,
NFkB) and the WNV-induced miRNA signature were virtually
indistinguishable in two otherwise isogenic cell lines, as was WNV
replication. This suggests that TLR3 signaling is dispensable for
the miRNA response to WNV infection.
Materials and Methods
Cells and viruses
For consistency we chose the same cell type, HEK293, as in
prior studies. HEK293-Null and HEK293-TLR3 cells were from
Invivogen, Inc (catalog # 293-Null and 293-htlr3). They were
maintained in DMEM supplemented with 10% FBS, Pen/Strep
and Blasticidin (10 mg/ml). WNV strain NY99 was obtained from
the ATCC. Virus was titered by plaque assay on Vero cells or
BHK cells as described [45].
Virus infection
HEK293-Null and -TLR3-expressing cells were seeded at
16107 cells in a 10 cm dish and infected with 16108 PFU
WNV (MOI = 10). As a negative control, equivalent amounts of
virus were inactivated using the methylene blue light inactivation
protocol [45,46] or by formalin inactivation (0.05% in phosphate
buffered saline) for 24 hours followed by three washes in
phosphate buffered saline (PBS). As a positive control, cells were
exposed to the TLR3 agonist polyI:C (5 mg/ml added to the cell
supernatant, Sigma catalog #42424).
Western blotting
Cells (16106 cells/well) were either left uninfected, treated with
inactivated (in.) virus or infected with West Nile Virus (MOI = 10).
Cells were harvested at various time points post-infection and lysed
in NP40 lysis buffer (50 mM Tris, 150 mM NaCl, 1% NP40
supplemented with protease inhibitor (Sigma catalog #P8340),
0.03% b-mercaptoethanol, 50 mM NaF, 1 mM sodium vanadate,
30 mM b-glycerophosphate and 1 mM PMSF). 20 mg of protein
(as determined by Pierce BCA Protein Assay) was loaded per well
and run on a 12% SDS - polyacrylamide gel. Following transfer of
proteins to a nitrocellulose membrane (HyBond, Amersham
Biosciences, Inc.), blots were incubated with rabbit anti-phos-
pho-IRF3 antibody (Epitomics, Inc.) at a 1:1000 dilution and
mouse anti-beta actin at 1:3000 dilution overnight at 4uC and then
washed three times with Tris-buffered saline with Tween (TBST).
Immunoblots were then probed with anti-rabbit and anti-mouse
HRP-conjugated antibodies at 1:5000 dilution (Vector Laborato-
ries, Inc.) for 2 hours at room temperature and washed again three
times with TBST. An ECL substrate kit (Pierce Inc. #32209) with
‘‘Blue Devil’’ X-ray film (Genesee#30–100) was used for
detection. Exposures from 10 seconds to 1 minute were taken,
showing similar results.
Immunofluorescence
HEK293-Null and HEK293-TLR3 cells were plated on
coverslips at 56105 cells prior to infection with WNV at an
MOI = 10. Cells were fixed in a 3% paraformaldehyde/PBS
solution for 15 minutes at room temperature followed by
incubation overnight in a blocking solution of 10% goat serum
(Vector Labs) in phosphate buffered saline (PBS) with 0.2% Triton
X-100. 100 ml of mouse monoclonal anti-WNV E (1:20 dilution;
Virostat Inc.) was spotted onto each coverslip and incubated
overnight at 4uC. For detection of phosphorylated p65, P-NF-
kappaB p65 (S536) primary antibody (clone 93H1, 1:100 dilution;
Cell Signaling) was used. Following three washes with PBS-0.2%
Triton with 2% BSA, anti-mouse Texas Red secondary antibody
(Vector Labs Inc. #TI-2000) and/or anti-rabbit Fluorescein
secondary antibody (Vector Labs Inc. #FI-1000) was added to the
coverslips at 1:500 dilution for 2 hours. Cells were then washed
three times with PBS-0.2% Triton X-100 with 2% BSA and
stained with 0.2 mg/ml DAPI (Sigma Inc.) prior to mounting in
VectaShield (Vector Labs Inc.). Images were taken on a Leica
DM4000B microscope with a Q-Imaging Retiga-2000RV camera
and HCX-PL-APO 506187 lens at 6306 magnification. De-
convoluted, merged images are shown (Simple PCI 6 software, 10
iterations RB or RGB fields).
WNV titration on the xCelligence system
Approximately 56103 cells/well were plated on an E-plate 16
(Acea Biosciences). After 4 hours, cells were infected with serial
dilutions of West Nile Virus (MOI = 5, 0.5, 0.05, etc.). Cell index
as a measure of viability was monitored continuously over a period
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of 100 hours. The time of peak cell index (in hours), which reflects
the onset of WNV-induced cytopathic effects, was also plotted for
each cell type against MOI for graphical representation of data.
RNA isolation and cDNA synthesis
Total RNA was isolated using Trizol (Sigma Inc.) as previously
described [47]. RNA quality was determined using the Agilent
RNA Nano 6000 kit as per the manufacturer’s protocol (Agilent
Inc.). All samples had a RNA integrity number (RIN) of .8.0. To
obtain cDNA, equal amounts of RNA as determined by Nanodrop
quantification were DNase treated (Ambion Inc.). The High
Capacity cDNA synthesis kit (Applied Biosystems Inc.) was then
used to reverse transcribe 100 ng DNase-treated RNA sample as
per the manufacturer’s instructions.
TLR3 RT-PCR
The cDNA was isolated from HEK293-Null and HEK293-
TLR3 cell lines as above. This was used as input for PCR of TLR3
expression using primers obtained from SA Biosciences (catalog
#PPH01803E). PCR products were then run on a 1% agarose gel
and visualized on a BioRad Gel Doc.
NFkB array
The cDNA isolated from the same WNV-infected Null and
TLR3 samples was also used as input for the 96-well qPCR array
of NFkB-responsive genes [48]. The Tecan Freedom Evo liquid
handling robot was used to setup the NFkB array for each sample
in duplicate. 10 ml reactions were run using SYBR Green-based
technology and the Roche LC480 real-time PCR system. ddCT
values were determined and data was clustered as described in the
calculations section.
Taqman miRNA profiling
The Taqman miRNA reverse transcription kit was used to
individually reverse transcribe 448 human miRNAs (Applied
Biosystems Inc.). Reactions were performed in 96-well format
using 10 ng total RNA per reaction. All reactions were assembled
using a Tecan FreedomEvo robot to limit pipetting error [49].
QPCR reactions were setup using the complete array of mature
miRNA specific primers and Taqman Universal PCR Master Mix
in a 384-well format. Each 11 ml reaction used 5 ml 26PCR
master mix, 2 ml 106QPCR primer (1.86 final primer concen-
tration) and 4 ml cDNA. QPCR was carried out in quadruplicate
on a LightCycler480 (Roche Inc.) using the standard Taqman
cycling program for 55 cycles.
Calculations and statistical analysis of miRNA profiling
data
To gain a general overview of the data set, we first calculated
the median raw expression measurement (CT) for each of the
miRNAs (n = 448). MiRNAs and structural small RNAs (RNU6B,
etc) were measured using the same calculation methods, beginning
with the raw CT readout from the Taqman small RNA assay.
MiRNAs were then normalized to the trimmed mean of 12
different structural RNAs. In Figure S1, panel A, the cumulative
density for n = 448 miRNAs measurements across 40 samples is
shown, summarizing 14,240 individual qPCR reactions. The
maximum cycle number was 55 as can be seen by a peak at
median CT of 55. Approximately 30% of all miRNAs had a
median CT of 55, i.e. these were not detected in a meaningful
fraction of the samples. MiRNAs with a CT.50 across all
conditions (i.e. not expressed) were excluded from further analysis,
yielding a total of 356 miRNAs. Next, we calculated the median
absolute deviation (mad) for each miRNA across all samples. The
mad is a more robust measure of variability compared to the
standard deviation. In Figure S1, panel B, the mad CT is plotted
against the median CT for each miRNA. The cumulative density
of the mads was also plotted (Figure S1, panel C). Approximately
17% of miRNAs had a mad = 0, which indicates that they did not
change across any of the experimental conditions. This indicates
miRNAs that were not detected in any of the samples. As seen in
Figure S1 panel B, miRNAs with a median CT.45 show a strong
linear relationship with the mad (blue line). This suggests
systematic, rather than biological variation. Hence, we set the
maximum CT = 45 cycles for all subsequent analyses. After this
adjustment, the median CTs followed a normal distribution, which
allowed us to use the sensitive t-test for individual comparisons.
The CT values were scaled by sample and subjected to
unsupervised hierarchical clustering using ‘‘Ward’s’’ agglomera-
tion method and the ‘‘Manhattan’’ distance metric. This method
was used to generate the heatmap representation of the data. As an
alternative approach, we used a second unsupervised genetic
clustering approach based on a Gaussian distribution model (data
not shown). This yielded essentially similar results, but also
suggested additional miRNAs as TLR3-dependent, such as miR-
542-3p, which exhibited some degree of differential expression.
To improve upon the sensitivity of our analysis even further, we
pursued specific comparisons. By-and-large, specific hypothesis
testing is a more sensitive analytical approach than unsupervised
clustering, which works best if there exist easily discernable groups
or clusters of genes. To detect changes between HEK293-NULL
and HEK293-TLR3, we conducted a t-test using the time points
2, 4, and 8 hrs post treatment. This yielded uncorrected p-values
representing the likelihood that any one miRNA differed in
expression between two treatments. These raw p values were then
adjusted for multiple comparisons testing using the q-value
method by Storey and Tibshirani [50]. Upon q-value correction
for polyI:C treatment and WNV infection, respectively
(pi0 = 0.907; 0.861), we obtained miRNAs with q#0.05.
WNV viral load
Viral load was determined by RT-qPCR as per our published
procedures [51] with primers: WNV Env F: 59-TCAGC-
GATCTCTCCACCAAAG-39; WNV Env R: 59-GGGTCAG-
CACGTTTGTCATTG-39. The following oligo was diluted to
generate a standard curve to determine copy number: WNV Env
Oligo: TCAGCGATCTCTCCACCAAAGCTGCGTGCCCG-
ACCATGGGAGAAGCTCACAATGACAAACGTGCTGACC-
C. A novel, engineered Nco I restriction site is denoted in italics
within the Env oligo sequence. Cutting the amplification products
with NcoI thus allowed us to exclude contamination by the
standard. Reactions were run on a Roche LightCycler 480 and
absolute copy number was determined by comparison to plaque
assay.
Gene ontology analysis
WNV-induced miRNAs obtained from Taqman profiling were
used for further analysis of functional downstream targets. The
dataset of miRBase IDs was input to Ingenuity Pathway Analysis
software (www.ingenuity.com) and predicted targets were obtained
[52]. The mRNA targets were then filtered through several
different parameters, excluding non-human genes and including
only experimentally validated targets. The top functional roles of
the remaining 550 targets were determined using the Ingenuity
software, and the statistical significance (p value) and number of
genes involved in each functional category are shown. For the
miRNA targets of individual Heatmap cluster subsets, Ingenuity
MiRNA Response to WNV Is Not TLR3-Dependent
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analysis was performed similarly. In cases where the number of
experimentally validated targets for the entire cluster was below
15, predicted mRNA targets with high confidence were also
included in the functional analysis.
Results
Assessing the role of TLR3 in the cell autonomous
response to WNV infection
Since previous studies of the role of TLR3 in WNV infection
have revealed both a protective host response as well as enhanced
in vivo pathogenesis, we characterized the cell autonomous
response to infection in the presence or absence of TLR3.
HEK293-TLR cells are widely used to dissect single TLR-specific
signaling events [53,54,55]. They have also been the cell line of
choice in prior studies on the role of individual WNV proteins,
such as NS1. HEK293-TLR3 cells ectopically express only TLR3
and HEK293-Null cells have very little to no expression of any of
the known TLRs. Minimal residual activity of TLR3 has been
reported in HEK293-Nulls (www.invivogen.com). Therefore, we
first confirmed the TLR3 status by RT-PCR. Only the HEK293-
TLR3 cells expressed TLR3 while TLR3 message levels were not
detected in the HEK293-Null cells, suggesting a ,1,000-fold
lower level in these cells (Figure 1A).
HEK293-Null and HEK293-TLR3 cells were infected with
WNV at an MOI of 5 and at 24 hours post-infection evaluated for
the presence of WNV envelope protein (E) by immunofluores-
cence. We chose this MOI and time course to ensure that every
cell is infected and represents synchronous WNV infection in
culture. Indeed, WNV E staining showed that 100% of HEK 293
Null were permissive to WNV infection at 24 hours (Figure 1B).
No differences in WNV infectivity were observed in HEK293-
TLR3 cells compared to HEK293-Nulls (Figure 1B). This finding
is consistent with prior studies [25,56].
We next investigated IRF3 activation. Upon infection, WNV
delays IRF3 phosphorylation and nuclear translocation to allow
for viral replication prior to the activation of anti-inflammatory
genes [12,57,58]. Figure 1C, D shows that IRF3 phosphorylation
is unaffected by inactivated virus and is triggered by WNV
infection between 24 and 36 hours post-infection. Similar kinetics
of IRF3 phosphorylation were observed regardless of the presence
or absence of TLR3; however, the amounts of phosphorylated
IRF3 appeared slightly elevated in TLR3-expressing cells com-
pared to Nulls at late times post infection. This is likely due to the
convergence of TLR3-dependent and –independent pathways of
IRF3 activation in HEK293-TLR3 cells at late times post-
infection (Figure 1D, 36 hpi).
We next assessed the IRF3 response to the TLR3 agonist
polyI:C. Treatment of HEK293-TLR3 cells with poly I:C led to
sustained phosphorylation of IRF3 as early as 8 hours post-
treatment, confirming that ectopically expressed TLR3 is func-
tional. By comparison to polyI:C treatment, IRF3 phosphorylation
was substantially delayed in HEK293-TLR3 cells following WNV
infection (Figure 1D, F). We also functionally tested the HEK293-
NULL cells for their response to the TLR3 agonist polyI:C
(10 mg/ml) added to the supernatant. Hyperstimulation of
HEK293-NULLs with poly I:C resulted in a modest, delayed
phosphorylation of IRF3 at one late time point, i.e. 24 hours post-
stimulation (Figure 1E). This is in contrast to HEK293-TLR3
cells, where robust IRF3 phosphorylation was evident by 8 hours
and sustained for up to 36 hours. This demonstrates that the
TLR3 response is severely curtailed in HEK293-Null cells. It is not
clear whether the minimal signal at very late times was the result of
polyI:C recognition by residual TLR3 or secondary events at late
times. Figure 1C-F serves as a control to show that the timing of
our infection process recapitulates the known biology of TLR3 and
WNV infection at the time when we profiled samples and the cells
(and hence RNAs) retain viability at a high MOI, i.e. 0 up to 8 or
at most 16 hours (not 36 hours). During the 0-16 hour time frame,
IRF3 experiences maximal phosphorylation in response to pI:C
when TLR3 is expressed (panel E and F), as has been documented
since the discovery of TLR3. In the 0–16 hour time frame, IRF3 is
not phosphorylated by WNV infection regardless of TLR3 status,
as has been documented many times [29,57,58,59].
The antiviral, innate immune response to WNV triggered by
PRR signaling eventually leads to cell death of infected cells.
Therefore, we next compared WNV cytopathogenicity in
HEK293-Null and HEK293-TLR3 cells using the xCelligence
method for determining cell death [60]. This novel assay provides
detailed insight into the kinetics of viral cytopathic effects. The
xCelligence platform is capable of continuously monitoring
cellular parameters such as adhesion, cell viability, cytotoxicity
and cell number using a label-free method. Cells are grown on
specialized plates coated with a microelectrode that measures
impedance, recorded as ‘‘Cell Index’’. Using this method, we
continuously monitored the cytopathic effects (CPE) of viral
infection in relation to MOI and also determined the onset of
virus-induced CPE for a given sample. HEK293-Null and
HEK293-TLR3 cells were plated at 5000 cells/well and infected
with 10-fold serial dilutions of WNV NY99 (MOI of 5, 0.5,
0.05…to 0.00005). Cytopathic effects induced by viral infection
were assessed continuously over a period of 100 hours. The
differences in the cell index (y-axis) reflect differences in cell
adhesion between HEK293- NULL and HEK293-TLR3 cells, the
latter being much less adherent. Importantly, both HEK293-Null
and –TLR3 cells were equally susceptible to WNV-induced CPE
(Figure 1G and H).
The peak cell index for each sample provides us insight into the
kinetics of WNV-induced cytotoxicity. We determined the WNV-
induced CPE kinetics for the different viral dilutions in the
presence and absence of TLR3. HEK293-TLR3 cells that were
mock-infected seemed to have slightly increased cell viability,
however this did not affect CPE kinetics. Figure 1I shows that the
kinetics of WNV-induced CPE follows a linear trend and
correlates well with the multiplicity of infection for each serial
dilution (R2 = 0.968). The onset of WNV-induced CPE was
independent of TLR3 status as determined by ANOVA compar-
ison of the MOI dependence fit curves (Figure 1G–I).
Since there were no differences in infectivity or cytopathic
effects regardless of TLR3 status, we next assessed whether TLR3
had any effect on WNV replication. Intracellular WNV replication
was determined by RT-qPCR using WNV oligonucleotides in
serial dilution to generate a standard curve for copy number.
WNV genomes were readily detected as early as 2 hours post-
infection and levels of intracellular virus increased steadily
throughout the course of infection (Figure 1J). Cellular TLR3
status had no significant effect on WNV intracellular RNA
replication by ANOVA using time, replicate and TLR3 status as
independent factors. This suggests that TLR3 does not limit
intracellular virus genome replication. Taken together, analysis of
the characteristic cellular responses to infection revealed that
although high levels of TLR3 expression increased IRF3
phosphorylation in response to WNV infection at late times, the
TLR3 status did not affect infectivity, viral genome replication or
WNV-induced CPE.
MiRNA Response to WNV Is Not TLR3-Dependent
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Figure 1. The cellular response to WNV infection is unaffected by TLR3 status. (A) RT-PCR analysis of TLR3 expression in HEK293-Null and
HEK293-TLR3 cells. RT negative reactions were performed as a control. (B) Immunofluorescence images of cells either mock- or WNV-infected are
shown. Cells were stained with WNV E antibody (red) and DAPI (blue) and merged, deconvoluted images are shown at 6306magnification. (C–F)
Western blots of phosphorylated IRF3 and beta actin in HEK293-Null and HEK293-TLR3 cells at various time points following WNV infection or post-
treatment with the TLR3 agonist poly I:C. Mock infected cells and cells treated with inactivated WNV are shown as controls. (G, H) xCelligence analysis
of cell viability following infection with serial dilutions of WNV NY99 (MOI = 5 to 0.00005). WNV-induced cytopathogenicity curves are shown for
HEK293-Null (G) and HEK293-TLR3 cells (H). Reads were taken every 30 minutes for a period of 100 hours. (I) WNV-induced CPE kinetics were obtained
by plotting the time of peak cell index for each sample against the concentration of WNV. HEK293-Nulls are represented by the blue line while
HEK293-TLR3s are denoted by the red line. This panel shows a linear regression across 5 log dilutions. Shown are the individual cell indices at each
dilution, the calculated robust linear regression lines (R2 = 0.968) and in the gray shading the standard error (SE) band across the entire dilution range.
(J) Viral load was determined by QPCR analysis for WNV envelope protein using a set of known WNV envelope standards. Panel J shows WNV copy
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NFkB signaling in response to WNV
Activation and nuclear translocation of NFkB and the
subsequent transcription of NFkB-responsive genes is a common
marker for triggering the host antiviral response. To test the NFkB
response to WNV, we performed an immunofluorescence assay to
monitor the status of phosphorylated NFkB p65 following
infection with WNV. Figure 2 demonstrates that upon WNV
infection, p65 becomes phosphorylated and translocates to the
nucleus in both infected HEK293-NULL and HEK293-TLR3
cells. This event happens early during infection, as phosphorylated
p65 was detected at 6 hours post-infection (Figure 2). WNV E
protein was detected following infection of both HEK293-NULL
and HEK293-TLR3 cells, while inactivated virus failed to yield
detectable phosphorylated p65 or WNV E staining. This
demonstrates that in contrast to IRF3 phosphorylation, which is
delayed until 36 hours following WNV infection, NFkB signaling
can be activated at early times post-infection and with it NFkB
responsive mRNA and miRNA transcription. NFkB signaling
represents another aspect of the antiviral response that can be
profiled to characterize the initial cellular response to WNV
infection.
We previously developed a qPCR-based array of ,90 NFkB-
responsive, experimentally validated genes [48]. To test the
hypothesis that TLR3 signaling influenced the quality of the
NFkB response, we analyzed the gene expression profile of NFkB
target genes in response to WNV infection. Prior to WNV
infection, both HEK293-Null and HEK293-TLR3 cells had low
basal levels of NFkB-responsive gene transcription (Figure 3A,
0 hpi). Induction of NFkB-responsive genes in WNV-infected cells
was compared to gene expression in cells treated with formalin-
inactivated virus, allowing for a signature of genes induced
specifically by productive WNV infection. Changes in gene
expression were detected as early as 2 hours post-infection,
suggesting that NFkB activation occurs much earlier than IRF3
activation, which occurred at about 36 hours post-infection.
HEK293-Nulls had a WNV-induced NFkB-responsive gene
expression profile with moderate induction of genes observed at
early times post-infection (Figure 3B). By comparison, HEK293-
TLR3s displayed significantly higher induction of key NFkB-
responsive genes. The WNV-induced NFkB-responsive gene
signature included IL-6, IL-8, IL-1b signaling, IRF1, subunits of
NFkB and matrix metalloproteinases (MMPs), which are known to
be involved in WNV pathogenesis [61,62,63,64,65,66,67,68].
Figure 3C shows the median CT across all samples and
demonstrates that all mRNAs within this WNV-induced NFkB
signature were present in both cell types at significant levels (i.e.
within the linear range of the qPCR assay) and Figure 3D shows a
heatmap of all NFkB-responsive genes profiled. Many well-known
NFkB target genes are not expressed in HEK293 cells at
number as determined by real-time qPCR using two biological replicate experiments (1 and 2) conducted one week apart. There was no significant
growth difference.
doi:10.1371/journal.pone.0104770.g001
Figure 2. WNV infection induces phosphorylated NFkB p65. HEK293-NULL and HEK293-TLR3 cells were infected with WNV (MOI = 10) and
fixed in 3% paraformaldehyde at 6 hours post-infection. Methylene blue inactivated virus was used as a control. Immunofluorescence assay (IFA) was
performed for phosphorylated p65 (green), WNV E (red) and DAPI (blue). Images are shown at 6306as individual panels, WNV E/p65 merge and full
merged images of WNV E/p65/DAPI.
doi:10.1371/journal.pone.0104770.g002
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sufficiently high levels to allow for meaningful statistical analysis
(even though heatmap-based clustering by the all inclusive nature
of this algorithm will assign an output color). We therefore limited
our statistical analysis to those mRNAs which were robustly
detectable in all biological and technical replicates, with a median
CT cutoff of 38 cycles across n = 18 samples (see Figure 3C). The
majority of those were induced to higher levels in WNV-infected
TLR3 cells compared to WNV-infected Null cells. This was,
however, a quantitative difference, not a qualitative difference. We
could not identify a single NFkB responsive mRNA, which was
induced only in WNV-infected TLR3 cells, but not in WNV-
infected Null cells; and we could not identify a single NFkB
responsive mRNA, which was induced only in WNV-infected Null
cells, but not in WNV-infected TLR3 cells. These data suggest
that NFkB is engaged in both HEK293-Null cells as well as in
HEK293-TLR3 cells. Whereas many NFkB targets were common
to both cells, indicative of the shared RIG-I/TRAF/TBK
signaling axis, others such as MMP1, cyclin D, IL-1 beta and
CD48 were more dramatically induced in TLR3 positive cells
compared to HEK293-NULLS.
miRNA profile of WNV infection in TLR3 positive and
TLR3 Null cells
Since miRNAs play a role in the host response to viral infection
and TLR signaling, we sought to identify the miRNAs that change
in response to WNV infection. This would provide us with another
class of biomolecules to characterize TLR3 dependent aspects of
the innate immune response to WNV infection. We employed a
Taqman-based QPCR array to quantify levels of 448 known
mature human miRNAs. Cells were infected with WNV at an
MOI of 5 or exposed to an equal amount of inactivated virus. The
miRNA profiles were determined at 0, 2, 4 and 8 hours post-
infection, and relative levels of expression were determined.
The CT values were scaled by sample and unsupervised
clustering was performed as described in the methods. The data
from these algorithms and QC analysis of the profiling data are
shown in Figure S1 and raw profiling data is shown in Table S9.
In Figure 4, orange/red indicates miRNAs that are more highly
expressed, blue indicates miRNAs that are absent, and yellow
indicates miRNAs expressed at intermediate levels. A large
number of miRNAs were not detectable in any sample, as
indicated by the blue bar underlay. The exception within this
group is cluster ‘‘d’’. Cluster ‘‘d’’ comprised miRNAs, which were
upregulated only in HEK293-NULL cells after WNV infection.
These included: miR-511, miR-563, miR-656, miR-630, miR-
487b and miR-539. Cluster ‘‘a’’ comprised miRNAs which were
abundantly expressed in all samples except untreated HEK293-
NULL cells and contained the miRNAs: miR-151, miR-140, miR-
9, miR-9*, miR-181a, miR-374, miR-100, miR-125b, miR-30b,
miR-182 and miR-423. Cluster ‘‘b’’ comprised miRNAs which
were consistently expressed in HEK293-TLR3 and decreased in
mock and WNV-infected HEK293-NULL cells and contained the
miRNAs: miR-592, miR-500, miR-193b, miR-497, miR-576,
miR-615, miR-28, miR-18a* and miR-491. Cluster ‘‘c’’ contained
miRNAs that were induced by continued culture (i.e. increased
with time cells spent in culture). These were: miR-362, miR-520b,
miR-429, miR-425, miR-566, miR-597, miR-502 and miR-628.
Finally, cluster ‘‘e’’ contained miRNAs, which were detectable in
HEK293-TLR3 cells, but were decreased in uninfected and
WNV-infected HEK293-NULL cells. These included miR-618,
miR-414d, miR-616, miR-96, miR-641, miR-548d, miR-579,
miR-486, miR-638, miR-642, miR-498 and miR-575.
To further improve upon the sensitivity of our analysis, we
selected a subset of miRNAs, requiring that in at least one sample
the miRNA was present in significant amounts (CT#28) and
normalized based on the 10% trimmed mean across 12
abundantly expressed structural RNAs (rnu6b-p3, rnu19, rnu24,
rnu38b, rnu43, rnu44, rnu48, rnu58a, rnu58b, rpl21, u47, u75).
This yielded the conventional dCT values as the basis of our
analysis for a set of 124 miRNAs.
To identify miRNAs that changed consistently upon infection,
we calculated for each the median across the 2, 4, and 8-hour
time-point and Z-standardized those by sample. As a result we
could calculate relative expression ratios between any two
conditions. The majority of miRNAs did not change drastically
upon treatment, particularly in HEK293-TLR3 cells (Figure 5).
There was evidence of generally lower miRNA expression upon
any treatment in HEK293-NULL cells, which could be evidence
of a general delay in proliferation or miRNA biosynthesis. Overall,
WNV and formalin-inactivated WNV induced similar trends in
miRNA changes. This would be consistent with the experience of
formalin-inactivated WNV without adjuvant in the vaccine setting,
where either particle induces a similar adaptive immune response
[69].
The most interesting comparison was in the HEK293 TLR3
cells (Figure 5C,D). Here, the background variation compared to
uninfected cells was so low for most miRNAs that changes in
individual miRNAs upon treatment stood out. Formalin-inacti-
vated WNV induced the miRNAs miR-567, miR-661, miR-154*,
miR-578 and miR-610, whereas live WNV infection did not
(Figure 5, panel C). Both preparations repressed a number of
miRNAs (miR-662, miR-600, miR-544, miR-487a, miR-493-3p,
miR-562). Treatment with the TLR3 agonist poly:IC dramatically
induced mir-143, whereas formalin-treated or live WNV did not.
Other miRNAs in this class were miR-367, miR-517*, miR-567
and miR-493-3p. Note that we only included miRNAs in the
comparison where at least one of the data points had a CT,28,
i.e. be so abundant that we could confirm detection by Caliper
nanofluidics based gel analysis (panel E), which yields both a gel
image and electropheregram for each lane. We have recently used
Caliper gel analysis as a method of visualizing miRNA expression
[70]. By separating the qPCR products on the Caliper nanofluidics
system which has higher resolution than agarose gels, we are able
to detect that miRNAs that are highly expressed produce a single
species, whereas undetected miRNAs and primers (CT.40) do
not produce a band of appropriate size (Figure 5E). This is
observed through the visualization of one single, specific peak at
the expected size of miRNAs and confirms the high specificity of
the miRNA assays.
To detect changes between HEK293-NULL and HEK293-
TLR3, we conducted a t-test using the time points 2, 4, and 8 hrs
post treatment. This yielded uncorrected p-values representing the
likelihood that any one miRNA differed in expression between two
treatments. Comparing changes in miRNA levels upon poly I:C
stimulation of either NULL or TLR3-expressing HEK293 cells, 7
miRNAs remained significantly changed to ,0.05 after adjust-
ment for multiple comparisons using the q-value method [50].
These were as follows: miR-20a, miR-99a, miR-517* (miR-517b
was significant in raw p-value), miR-519b, miR-583, miR-651 and
miR-662. Comparing changes in miRNA levels upon WNV
stimulation of either NULL or TLR3-expressing HEK293 cells,
our analysis yielded 45/125 (36%) miRNAs with an unadjusted
p#0.05. Few miRNAs remained significantly changed to ,0.05
after adjustment for multiple comparisons. These were as follows:
miR-20a, miR-99a, miR-517, miR-683, miR-587, miR-651 and
miR-662.
Overall, the statistical analyses of our profiling data demonstrate
that there were very few changes in miRNA expression following
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WNV infection or treatment with inactivated virus. Changes in the
miRNA profile induced by WNV were rather consistent between
cell types and the WNV miRNA signature was not significantly
affected by the presence or absence of TLR3. These data further
suggest that the majority of WNV-regulated miRNAs at early times
post-infection (8 hrs) are not TLR3-dependent, but may depend on
signaling through other PRRs such as RIG-I and MDA5 and/or
other sensors like PKR (RIG-I, MDA5 and PKR are fully functional
in HEK293 cells) [71,72,73,74,75,76,77,78,79].
We then compared the miRNA response to WNV infection and
stimulation of TLR3 via polyI:C treatment. Figure 6 shows a
Venn diagram illustrating that the majority of WNV dependent
miRNAs (n = 70) were induced in both HEK293-TLR3 and –
NULL cells. Only 4 were induced only in HEK293-TLR3 cells.
Furthermore, the miRNA profile following engagement of TLR3
signaling through polyI:C treatment yielded a relatively distinct
profile compared with WNV infection: 41 miRNAs were shared
between WNV infected cells and polyI:C induced TLR cells but
none were specific to HEK293-TLR3 cells. There were 53
miRNAs uniquely induced just by polyI:C in HEK293-TLR3
cells. These data suggest that WNV-induced miRNAs predomi-
Figure 3. WNV infection induces a unique NFkB-responsive gene expression profile. HEK293-Null and –TLR3 cells under the specified
conditions were analyzed for gene expression profiles using a qPCR array consisting of ,90 NFkB-responsive genes. (A,B) Fold induction of genes
was calculated by comparing WNV-infected samples to cells treated with formalin-inactivated virus. WNV-induced gene expression is shown at
0 hours post-infection (A) and 2 hours post-infection (B) with WNV (MOI = 10). Black bars denote TLR3-expressing HEK293 cells while open bars
represent HEK293-Nulls. (C) The median CT across all samples was calculated and is shown +/2 SEM for each gene analyzed. All genes shown were
abundantly expressed (CT,35). (D) Heatmap of NFkB genes profiled. Highly abundant miRNAs are indicated by red and non-expressed miRNAs by
blue color. Yellow indicates an intermediate expression level. This is also shown underneath the heatmap. The miRNAs were clustered based on
expression.
doi:10.1371/journal.pone.0104770.g003
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nantly respond to signaling events independent of TLR3 or that
miRNA response to WNV was substantially dampened.
WNV-induced miRNA targets have functional roles in
infection
Since miRNAs often work in combination to confer a functional
phenotype, we next investigated the combined effect of miRNA
changes in WNV-infected cells by analyzing induced miRNAs
from the WNV signature for predicted functional roles in WNV
pathogenesis. WNV-specific miRNAs were analyzed using Inge-
nuity Pathway Analysis (IPA). Experimentally validated miRNA
targets were obtained and subjected to gene ontology analysis,
separating the target genes into functional categories. We also
performed pathway analysis of predicted miRNA targets in each
unique cluster from Figure 4 (Tables S1,S2,S3,S4,S5 for clusters a-
e, respectively). MiRNAs induced by treatment with the TLR3
agonist were also analyzed by pathway analysis of predicted targets
(Tables S7, S8).
Several functional categories were significantly linked to the
WNV-induced miRNA signature (Figure 7). The largest number
of target genes affected functions such as cell proliferation, cell
death, gene expression and infectious disease (Figure 7A). WNV is
known to affect cell death and proliferation throughout the course
of infection to allow for efficient viral replication and spread of the
virus through apoptosis and cell lysis. The infectious disease
category also included many WNV-linked functions, such as
immune cell trafficking and viral replication. These are further
specified in the more detailed functions of target genes shown in
Figure 7B. Several processes related to proliferation, recruitment
and transmigration of cells were also listed, suggesting a potential
role of these miRNA targets in WNV neuropathogenesis.
Functional analysis remains to be performed and will further shed
light on the role of these miRNAs and specific targets in WNV
pathogenesis. As a control, we also analyzed the target genes of
miRNAs induced by infection of B cells with an unrelated virus,
Kaposi sarcoma Herpesvirus (KSHV) [80]. This verified that the
WNV-induced miRNA targets had a distinct gene ontology profile
from this control. There were several pathways that were
significantly changed upon infection with WNV but considered
N/A or not significant in KSHV-infected cells (data not shown).
Notably, these included the immune and neural related pathways.
Discussion
The host response to WNV infection is regulated by multiple
PRRs that sense the invading viral ss and dsRNA: RIG-I, TLR3
and PKR. RLR signaling involving RIG-I, MDA5 and the
common adapter protein IPS-1 is essential to control WNV
infection in mice and in culture [12,16,17,81]. TLR3 has been
shown to influence WNV pathogenesis both positively and
negatively in vivo, by aiding in mounting a protective immune
response and by enhancing infection and neuropathogenesis
[25,26,27,29].
Most of the studies so far used in vivo infection models. To
further characterize the cell-intrinsic role of TLR3, we assessed
viral replication and the cellular response to WNV in the presence
or absence of functional TLR3 (Figure 1). Minimal residual
activity of TLR3 has been reported in HEK293-Nulls (www.
invivogen.com). However, TLR3 message levels were undetect-
able in HEK293-NULLs and hyperstimulation of these cells with
polyI:C resulted in a significantly delayed IRF3 response
compared to HEK293-TLR3 cells, which may in fact be due to
secondary unspecific events. Therefore, HEK293-NULLs were
considered to have very low levels of TLR3 activity and our
profiling was conducted at early times (,8 hours). TLR3-
overexpressing HEK293 and HEK293NULL cells could be
productively infected with WNV (Figure 1), yielding similar
intracellular viral loads and CPE profiles in response to infection.
WNV staining by immunofluorescence was also identical regard-
less of cellular TLR3 status. Only HEK293-TLR3 responded to
polyI:C treatment by phosphorylation of IRF3 at 8 hours. We
observed increased phosphorylation of IRF3 in HEK293-TLR3
cells compared to HEK293-NULLs likely due to the convergence
of TLR3-dependent and RIG-I-dependent signaling events in
response to WNV at late times post-infection. This characteristic,
delayed activation of IRF3, was observed in HEK293-TLR3 and
HEK293-NULL upon WNV infection. It was independent of
Figure 4. MiRNA profiling reveals a WNV-induced signature. Large-scale miRNA profiling was carried out in HEK293-Null and –TLR3 cells
using Taqman-based qPCR. Heatmap representation of all raw data points for the experiment. Sample abbreviations are as follows: UN – mock
infected cells; WNV – WNV-infected cells; polyIC – cells treated with TLR3 agonist polyI:C; MB – cells exposed to methylene blue-inactivated WNV;
Form – cells exposed to formalin-inactivated WNV. Highly abundant miRNAs are indicated by red and non-expressed miRNAs by blue color. Yellow
indicates an intermediate expression level. This is also shown underneath the heatmap. The miRNAs were clustered based on expression. The
dendrogram is shown on the top and interesting clusters are highlighted in green and indicated by small letters (a high resolution figure is presented
as Figure S2).
doi:10.1371/journal.pone.0104770.g004
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TLR3 status, as was early activation of nuclear phospho-NFkB
(Figure 2). This would indicate that NFkB signaling was engaged
by WNV independent of TLR3.
More in-depth analysis of downstream NFkB-responsive genes
demonstrated that WNV does indeed induce a specific NFkB-
regulated signature (Figure 3). This unique profile consists of many
cytokines and inflammatory genes involved in mounting an
effective immune response against WNV infection. Though
HEK293-NULLs mounted a robust NFkB signature following
infection, the majority of NFkB targets were upregulated to a
greater extent in HEK293-TLR3 cells following WNV infection.
This quantitative enhancement is presumably due to the additive
effect of NFkB activation via both TLR3-dependent and TLR3-
independent mechanisms. In addition, we observed qualitative
differences in the NFkB response profile (Figure 3).
Figure 5. Directed Comparison of abundant miRNAs. All miRNAs with at least one data point had a CT#28 were selected, normalized to stable
small RNAs, and the median CT across the 2, 4, and 8 hr time point was calculated. These were further standardized to yield a Z score, which reflects
relative changes. The Z score is shown on the vertical axis and miRNAs on the horizontal axis. The Z scores were ordered by the level of uninfected
HEK293-Null (A, B) or HEK293-TLR3 (C, D) cells. Panels (A) and (C) compare the response of WNV to formalin-inactivated virus. Panels (B) and (D)
compare the response of WNV infection to polyI:C stimulation. (E) Caliper LabChip analysis of a highly expressed and undetected miRNA. qPCR
products of miRNA assays were run on a Caliper LabChip GX and the resulting electropheregram is shown. The sample yields a single peak
corresponding to the expressed miRNA and two assay marker bands (UM – upper marker and LM – lower marker). The undetected miRNA
electropheregram shows only an upper and lower marker peak with very little to no background signal, confirming the high specificity of this assay.
doi:10.1371/journal.pone.0104770.g005
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MiRNAs control many cellular processes including apoptosis,
oncogenesis and the regulation of the immune responses [40,82].
We profiled host cellular miRNAs in response to WNV infection
(Figures 4, 5). The majority of miRNAs did not change,
demonstrating that there was not a global impact on mature
miRNA levels within the timeframe that is relevant for productive
infection. One of the possible reasons why miRNAs were not
affected is their high stability. Since mature miRNAs have a
relatively long half-life of ,5 days [83], the overall levels of mature
miRNAs may change very little during infection with rapidly
replicating viruses. Alternatively, miRNA biosynthesis may be
globally downregulated. Shapiro et al. demonstrated that upon
infection with an RNA virus, Drosha is dramatically relocalized to
the cytoplasm [84]. Others also reported global dampening of
miRNA expression in productive viral infections, perhaps in an
effort to enhance the immediate interferon response [41,42]. In
addition, differentiated cells show inhibition of the RISC
compared to pluripotent cells and may have attenuated activity
of another component of the miRNA processing machinery, Dicer
(reviewed in [40]).
Although there was no global miRNA effect induced by WNV,
we identified and validated specific miRNAs that constitute a
WNV–specific miRNA signature. Most of these miRNAs were
induced in TLR3-positive as well as TLR-negative cells, suggesting
that they respond to TLR-independent signaling events (Figure 6).
This was in contrast to poly I:C responsive miRNAs. The
cytoplasmic helicases RIG-I and MDA5 play an important role in
WNV recognition and the host cell response to infection
[12,17,57,81,85,86,87]. Specifically, a model was proposed that
RIG-I may be responsible for the immediate early response to
infection and that the function of TLR3 may be in sustaining this
response [17,57,58,81,85,86]. PKR and the OAS/RNaseL
pathway also remain important dsRNA sensors during WNV
infection [19,20,21,22,88]. Such a model would be consistent with
our profiling data, as we observed dramatic RNA changes already
at early times (2–4 hours) after infection, whereas TLR3-
dependent phosphorylation of IRF3 was not induced until much
later (Figure 1C, 36 hpi).
WNV was previously shown to inhibit TLR3 signaling through
NS1 although another study of the nonstructural proteins from
multiple flaviviruses failed to see this phenotype [28,29,30]. We
Figure 6. Venn diagram of miRNAs that were induced in HEK293 Null and HEK293 TLR3 cells. Venn diagram representation of miRNAs
induced following WNV infection of HEK293-Null and HEK293-TLR3 cells or polyI:C stimulation of HEK293-TLR3 cells. The number of shared, induced
miRNAs are shown for each sample subset. A detailed list of the miRNAs induced for each category represented in the Venn diagram (HEK293-NULL +
WNV, HEK293-TLR3 + WNV and HEK293-TLR3 + polyI:C treatment) is shown in Table S6.
doi:10.1371/journal.pone.0104770.g006
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observed a different miRNA profile for polyI:C stimulated TLR3
cells compared to WNV infected TLR3 cells, as demonstrated in
the Venn diagram of induced miRNAs (Figure 7). These miRNAs
are also shown in detail in Table S6. This, together with delayed
IRF3 phosphorylation (Figure 1), confirms that WNV indeed
abrogates TLR3 signaling.
Smith et al. also reported a miRNA profiling study in response
to WNV infection in HEK293 and SK-N-MC cells and identified
a subset of about 24 miRNAs induced in WNV-infected cells [37].
It is difficult to compare these studies directly due to differences in
cells, experimental methods and profiling techniques (qPCR versus
microarray). Differences in profiling techniques alone are known
Figure 7. WNV-induced miRNAs target processes functionally relevant to WNV pathogenesis. WNV signature miRNAs were analyzed for
functions of predicted targets using Ingenuity Pathway Analysis software (IPA). Predicted targets of these miRNAs were determined and filtered
through several criteria to yield functional categories for target genes. (A) The top functional categories are represented and the number of miRNA
target genes in each category is denoted. (B) More detailed functions of the WNV-induced miRNA targets. Functions are shown along with statistical
significance (P value) and the number of genes that correspond to each function. The p value was calculated in IPA using the right-tailed Fisher Exact
Test and compares the number of focus genes that participate in a given functional process and the total number of genes known to be associated
with the function in the selected set of miRNA target genes.
doi:10.1371/journal.pone.0104770.g007
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to contribute to the variation of datasets [70]. Smith et al. reported
that a molecule termed hs_154 was significantly induced following
WNV infection [37]. At the time of their publication and design of
this TaqMan array, this was not a known miRNA in miRbase. It
has since been added to mirBase and is known as hsa-miR-6124
(GGGAAAAGGAAGGGGGAGGA). Out of the 24 miRNAs
Smith et al. reported as WNV-induced, 6 miRNAs were included
in our Taqman miRNA profiling assays. We confirmed 4 of these
(miR-33, miR-299-5p, miR-335, miR-563), which were also
induced in our study. All had very low expression levels, with
miR-563 being the most consistent among them. One of the 6
miRNAs was downregulated rather than induced (miR-494) and
one (miR-603) had an inconclusive profile in the Taqman assay.
We were not able to demonstrate a functional impact of any one
miRNA on WNV replication in this system (data not shown). This
is perhaps not unexpected because WNV in tissue culture is
extremely robust, much more so than during primary infection of
specialized immune cells such as Langerhans or endothelial cells.
In culture, WNV and most other ‘‘rapid’’ viruses are not affected
by any host miRNAs [89].
Conclusions
Taken together, our data reveal a WNV associated miRNA
signature that includes miRNAs that target functionally relevant
processes important to WNV pathogenesis. Comparison of Null
and TLR3-expressing HEK293 cells further demonstrates that
other PRRs primarily initiate the NFkB-driven and the miRNA
response to WNV infection and that TLR3 expression does not
directly affect viral replication or cytotoxicity. Collectively, this
suggests that while TLR3 may play an important role in viral entry
to the CNS and BBB disruption, TLR-independent mechanisms
such as RIG-I and MDA5/IPS-1 primarily control the immediate,
cellular response to infection, including characteristic, WNV-
induced miRNA responses.
Supporting Information
Figure S1 QC analysis of miRNA profiling data and
application of statistical algorithms. Large-scale miRNA
profiling was carried out in HEK293-Null and –TLR3 cells using
Taqman-based qPCR. Methods used to generate this analysis are
described in detail within the Methods section. (A) shows the
cumulative distribution (on the vertical axis) of the median CT (on
the horizontal axis) for each of the miRNA assays across all
samples. (B) shows the median absolute deviation (mad) on the
vertical axis compared to the median CT on the horizontal axis for
each of the miRNA assays across all samples (Using median and
mad is more outlier resistant than using mean and standard
deviation). (C) shows the cumulative distribution (on the vertical
axis) of mad CT (on the horizontal axis) for each of the miRNA
assays across all samples.
(TIF)
Figure S2 High Resolution Image of WNV-induced
miRNA profiling figure (Figure 4). Large-scale miRNA
profiling was carried out in HEK293-Null and –TLR3 cells using
Taqman-based qPCR. Heatmap representation of all raw data
points for the experiment. Highly abundant miRNAs are indicated
by red and non-expressed miRNAs by blue color. Yellow indicates
an intermediate expression level. This is also shown underneath
the heatmap. The miRNAs were clustered based on expression.
The dendrogram is shown on the top and interesting clusters are
highlighted in green and indicated by small letters.
(PNG)
Table S1 Ingenuity Functional Analysis of miRNA
Targets from Heatmap Cluster ‘‘a.’’
(DOCX)
Table S2 Ingenuity Functional Analysis of miRNA
Targets from Heatmap Cluster ‘‘b.’’
(DOCX)
Table S3 Ingenuity Functional Analysis of miRNA
Targets from Heatmap Cluster ‘‘c.’’
(DOCX)
Table S4 Ingenuity Functional Analysis of miRNA
Targets from Heatmap Cluster ‘‘d.’’
(DOCX)
Table S5 Ingenuity Functional Analysis of miRNA
Targets from Heatmap Cluster ‘‘e.’’
(DOCX)
Table S6 MicroRNAs from Venn Diagram analysis. This
table shows a list of microRNAs induced by WNV infection and
polyI:C treatment in HEK293 cells. Each column details the
microRNAs for the Venn diagram analysis (Figure 7). MicroRNAs
unique to each treatment column are denoted in bold font with
grey background. MicroRNAs that met the hard criteria defined
for analysis in Figure 5 are denoted with a dash (2).
(DOCX)
Table S7 Ingenuity Functional Analysis of miRNA
Targets from polyI:C induced microRNAs (Unique to
pI:C treatment). MicroRNAs uniquely upregulated by polyI:C
treatment in HEK293-TLR3 cells were analyzed using Ingenuity
pathway analysis software. Gene ontology categories and functions
of these microRNA targets are shown.
(DOCX)
Table S8 Ingenuity Functional Analysis of miRNA
Targets from abundantly expressed polyI:C induced
microRNAs (Unique to pI:C treatment). Abundantly
expressed microRNAs that were uniquely upregulated following
polyI:C treatment in HEK293-TLR3 cells were identified using
the hard cutoff criteria described for Figure 5. Targets of these
microRNAs were analyzed using Ingenuity pathway analysis
software and gene ontology categories and functions are shown.
(DOCX)
Table S9 CTs of miRNA Profiling Data. Table of the raw
CTs from all samples profiled.
(XLS)
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